Voya Investment Management LLC Sangamo Therapeutics, Inc Transaction History

Voya Investment Management LLC

$80 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Feb 07, 2025	BUY	$0.42 - $1.38 $22,560 - $74,126	53,715 New	53,715 $35,000
Q1 2024 Dec 06, 2024	BUY	$0.42 - $1.38 $22,560 - $74,126	53,715 New	53,715 $35,000
Q1 2024 May 15, 2024	BUY	$0.42 - $1.38 $6,996 - $22,989	16,659 Added 44.96%	53,715 $35,000
Q4 2023 Feb 07, 2025	SELL	$0.3 - $0.63 $6,334 - $13,301	-21,114 Reduced 36.3%	37,056 $20,000
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $6,334 - $13,301	-21,114 Reduced 36.3%	37,056 $20,000
Q2 2023 Feb 07, 2025	BUY	$1.11 - $1.74 $9,603 - $15,054	8,652 Added 17.47%	58,170 $75,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $9,603 - $15,054	8,652 Added 17.47%	58,170 $75,000
Q1 2023 Feb 07, 2025	BUY	$1.66 - $3.67 $82,199 - $181,731	49,518 New	49,518 $87,000
Q3 2022 Feb 07, 2025	BUY	$4.27 - $6.39 $211,441 - $316,420	49,518 New	49,518 $242,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $12,639 - $18,914	2,960 Added 6.36%	49,518 $243,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $7,771 - $11,694	-1,066 Reduced 2.24%	46,558 $349,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $28,577 - $35,518	-2,810 Reduced 5.57%	47,624 $570,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $1,555 - $2,438	143 Added 0.28%	50,434 $632,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $93,019 - $183,218	10,078 Added 25.06%	50,291 $785,000
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $107,830 - $205,416	-17,364 Reduced 30.16%	40,213 $360,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $9,362 - $16,407	1,854 Added 3.33%	57,577 $367,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $93,348 - $136,012	11,625 Added 26.36%	55,723 $466,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $18,716 - $27,871	2,139 Added 5.1%	44,098 $475,000
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $20,465 - $35,723	2,152 Added 5.41%	41,959 $482,000
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $38,544 - $54,905	2,773 Added 7.49%	39,807 $565,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $16,583 - $26,165	-993 Reduced 2.61%	37,034 $704,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $319,426 - $570,405	38,027	38,027 $570,000

Others Institutions Holding SGMO

# of Institutions

113

Shares Held

57.8M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.6 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$10.9 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.63 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.46 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.73 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account